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Objective: Delayed gadolinium enhanced magnetic resonance imaging (MRI) of cartilage (dGEMRIC) fa-
cilitates non-invasive evaluation of the glycosaminoglycan content in articular cartilage. The primary aim
of this study was to show that the dGEMRIC technique is able to monitor cartilage repair following
regenerative cartilage treatment.
Design: Thirty-one patients with a focal cartilage lesion underwent a dGEMRIC scan prior to cartilage repair
surgery and at 3 and 12 months follow-up. At similar time points clinical improvement was monitored
using the Knee injury and Osteoarthritis Outcome Score (KOOS) and Lysholm questionnaires. Per MRI scan
several regions-of-interest (ROIs) were deﬁned for different locations in the joint. The dGEMRIC index
(T1gd) was calculated for each ROI. Repeated-measures analysis of variance (RMANOVA) analysis was used
to evaluate improvement in clinical scores and MRI T1gd over time. Also regression analysis was per-
formed to show the inﬂuence of local repair on cartilage quality at distant locations in the knee.
Results: Clinical scores and the dGEMRIC T1gd per ROI showed a statistically signiﬁcant improvement
(P < 0.01), from baseline, at 12 months follow-up. Also, improvement from baseline in T1gd of the ROI
deﬁning the treated cartilage defect showed a direct relationship (P < 0.007) to the improvement of the
T1gd of ROI at other locations in the joint.
Conclusions: The dGEMRIC MRI protocol is a useful method to evaluate cartilage repair. In addition, local
cartilage repair inﬂuenced the cartilage quality at other location in the joint. These ﬁndings validate the
use of dGEMRIC for non-invasive evaluation of the effects of cartilage regeneration.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Focal articular cartilage lesions in the knee are frequently
treated by microfracture or autologous chondrocyte implantation
(ACI)1. Treatment failure, is often related to inadequate tissue
regeneration2. Also, good structural repair at short-term follow-up
showed to result in good clinical outcome at later time points3,4.
In clinical trials, the success of cartilage regeneration is usually
determined by histological evaluation of regenerated tissue ob-
tained from an additional cartilage biopsy from the newly formed: D.B.F. Saris, Department of
00, 3508 GA Utrecht, The
.
).
s Research Society International. Ptissue. The disadvantages of a cartilage biopsy and themain reasons
for which it has not been introduced as a standard protocol in
clinical practice, are the invasive nature of the procedure and the
fact that it only provides local information. Therefore, a non-
invasive method to determine tissue organization and to assess
the distribution of relevant articular cartilage matrix proteins
would be of great value in the evaluation of tissue regeneration.
The non-invasive MR imaging technique called delayed gadolin-
ium enhanced magnetic resonance imaging (MRI) of cartilage
(dGEMRIC) can be used to assess the concentration of glycosamino-
glycans (GAGs) in the extracellular cartilage matrix5. This technique
is based upon the negatively charged ions of the T1-shortening
contrast agent gadolinium diethylene triamine pentaacetic acid
(Gd-DTPA2, Magnevist) that distribute inversely proportional to theublished by Elsevier Ltd. All rights reserved.
Table I
Baseline characteristics
Patients
(n ¼ 31)
Gender
Male n (%) 23 (74%)
Female n (%) 8 (26%)
Age mean  SD 36  11
<30 jr n (%) 12 (39%)
>30 jr n (%) 19 (61%)
Type of treatment
MACI/characterized chondrocyte implantation (CCI) n (%) 12 (39%)
Microfracture (MF) n (%) 12 (39%)
Chondron n (%) 7 (22%)
Defect age* mean (months)  SD 24  17
<2 y n (%) 12 (50%)
>2 y n (%) 12 (50%)
Defect size mean (cm2)  SD 4  2
<3 cm2 12 (39%)
>3 cm2 19 (61%)
* Defect age from Chondron treatment patients is missing.
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lage. TheGd-DTPA2 concentrationper voxel isdescribedbymeansof
the dGEMRIC index (T1gd)which is calculated from the ﬁve different
inversion times using a curve ﬁtting method. In areas with low GAG
the calculated T1gdwill be low, and vice versa. A good correlationwas
found between the biochemically determined GAG contents and the
related T1gd times in ex vivo studies5,6. In addition, it was shown that
the dGEMRIC technique can be used to evaluate the quality of artic-
ular cartilage after osteochondral autologous transplantation, high
tibial osteotomy and matrix-assisted ACI (MACI)7e11.
In addition to the availability of techniques evaluating the
outcome of defect treatment, it is becoming increasingly evident that
its success is directly dependent on patient characteristics12. Factors
such as age and gender of the patient and size, age and location of the
focal lesion were shown to inﬂuence clinical outcome after regener-
ative cartilage therapy12. However, it is not known to what extent
these characteristics also affect the biological repair response.
Therefore, the primary aim of this study was to show that the
dGEMRIC technique is able to monitor cartilage repair following
regenerative cartilage treatment. We also evaluated to what extent
local cartilage repair inﬂuences the cartilage quality in the whole
knee. Also, speciﬁc patient and defect characteristics were evalu-
ated for their inﬂuence on cartilage repair.
Material and methods
General study outline and patient population
This study was conducted with approval of the institutional
ethical committee under protocol number 08-022/E. Patientswith a
substantial decrease in sports participation or limitations in activ-
ities of daily living combined with a strong suspicion of a focal
(osteo)chondral lesion on MRI were planned for arthroscopy and
indicated for treatment, with either microfracture, MACI, Chon-
droCelect or Chondron treatment13. These patients were eligible for
inclusion in this study. If patients signed consent a preoperative
dGEMRIC scan was obtained. Patients with general contraindica-
tions for MRI scanning, a known allergic reaction to gadolinium-
containing contrast agents or with a history of kidney pathology
were considered not eligible for inclusion. If, during arthroscopy, the
treating physician found that the lesion or other cartilage surfaces
were not suitable to receive any of the abovementioned treatments,
the included patient was excluded from the study. From April 2009
to March 2010 a total of 40 patients diagnosed with a symptomatic
(osteo)chondral focal articular cartilage lesion met the inclusion
criteria and were willing to participate in this study. The study
procedures and risks were explained and, after a minimum of 14
days, informed consent was obtained by a physician not involved in
the diagnostic and therapeutic process (JEJB). One patient was
excluded when receiving her ﬁrst study MRI because of MRI arte-
facts possibly resulting from previous anterior cruciate ligament
reconstruction. In addition, seven patients were excluded during
surgery for two reasons; they either showed generalized cartilage
degeneration (n ¼ 2) or the characteristics of the lesion were not
suitable for abovementioned treatments (n ¼ 5). One patient was
lost to follow-up at 12months. The baseline characteristics of the 31
patients who were included and completed the study are provided
in Table I. All included patients were evaluated before surgery (on
average 33  18 days, range 1e78 days) as well as 3 and 12 months
after surgerybyadGEMRIC examination and clinical questionnaires.
Cartilage evaluation by dGEMRIC
All dGEMRIC scans were performed on a 1.5-T clinical MRI
scanner (Achieva, Philips Healthcare, Best, The Netherlands) using adedicated eight-element sense knee coil as a receiver (Philips
Healthcare, Best, The Netherlands). Scanning took place 90 min
after intravenous injection of Magnevist (Gd-DTPA2, Bayer, Ger-
many) at a dose of 0.2 mmol/kg body weight. After survey scans, a
transient ﬁeld echo (TFE) pulse sequence was used for dGEMRIC
with ﬁve different inversion delay times (50, 150, 350, 650 and
1650 ms), as previously described by McKenzie et al.14 A total of 36
partitions were obtained with a 256  232 in plane acquisition
matrix resulting in a voxel size of 0.625  0.625  3 mm3, using an
echo time of 4.3 ms, a repetition time of 10 ms and a ﬂip angle of 20
degrees. The average T1Gd per region-of-interest (ROI) was calcu-
lated after voxelwise ﬁtting of the dGEMRIC signal equation as a
function of inversion time using the LevenbergeMarquardt non-
linear least-squares method implemented in in-house developed
software. On the sagittal images obtained in the dGEMRIC scanwith
an inversion delay time of 350ms a total of six different ROIs (Fig.1)
were drawn using a smartboard with projection on an interactive
screen. The defect ROI was the region of the treated defect. The
cartilage segmentation in the defect ROI was separated from the
adjacent (non) defect cartilage using the length, width and size of
the defect (obtained from surgery reports). Based on the voxel size
of the obtained dGEMRIC scans we calculated the number of slices
and width of the defect on the sagittal images for segmentation. In
the articular cartilage directly opposing and articulating with the
treated defect the articulating ROI was drawn. The three joint
compartments, patellofemoral, lateral and medial tibiofemoral,
were, depending on the site of the cartilage defect, separately
identiﬁed as the treated ROI and two other ROIs. Finally awhole knee
ROI was created that consisted of a segmentation of all the articular
surfaces in the knee. All segmentations were performed by one
person (JEJB) and consensus with an experienced knee specialized
orthopedic surgeon was obtained in case of any doubts. Baseline
ROIs were used and plotted on the follow-up scans at 3 and 12
months to guarantee similar sized ROIs over time. For a set of 15
scans all ROIs were, with an interval of 1 month, repeated by the
same observer to evaluate the internal consistency and reliability of
the segmentation process.
Evaluation of clinical outcome
The clinical treatment outcomewas assessed using two different
questionnaires both validated for the evaluation of the clinical
status of patients treated for an articular cartilage lesion15,16.
The Knee injury and Osteoarthritis Outcome Score (KOOS) was
designed to evaluate the short- and long-term follow-up of
Fig. 1. ROIs. Sagittal MRI slices of the scan with 350 ms inversion delay time showing example ROI segmentations as a color overlay. The color bar represents the calculated T1gd in
milliseconds, where a high T1gd (1000 ms) is depicted as blue and a low T1gd (nearly 0 ms) as red.
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questionnaire was validated to measure the clinical condition in
patients after regenerative cartilage surgery15. The KOOS consists of
ﬁve subdomains; symptoms, pain, activities of daily living, function
in sport and recreation and knee-related quality of life. The KOOS
score per subdomain (score 0e100) was calculated using the free
available scoring sheet on the KOOS website (http://www.koos.nu/).
The Lysholm questionnaire was initially designed to evaluate
the functional disabilities resulting from ligamentous injury.
Recently, this questionnaire has also been validated to asses artic-
ular cartilage damage16. The questionnaire consists of eight do-
mains (pain, instability, locking, swelling, limping, walking stairs,
squatting and keeping support) and translates to a score between
0 and 100 (normal knee function).
Statistical analysis
All statistical analyses were performed using SPSS statistical
software version 15.0 (Chicago, USA). Internal consistency of the
segmentation process was performed by the Cronbach’s alpha and
the reliability using the intraclass correlation coefﬁcient (ICC).
Repeated-measures analysis of variance (ANOVA)
Absolute improvement from baseline at 3 and 12 months follow-
up for (subdomains of) the clinical questionnaires and ROIs was
calculated (by extracting the baseline values from the 3 and 12month
values) and testedusing a repeated-measuresANOVAwitha repeated
model ﬁt. All variables showed a normal distribution (Kolmogorove
Smirnov P > 0.05) equality of variance (Levene’s test P > 0.05) and
met the assumption of sphericity (Mauchly’s test P> 0.32) and could
therefore validly be included in the repeated-measures model.
To correct for a false positive interpretation of statistical sig-
niﬁcance among the multiple tests that were performed to show
the, possible, improvement over time of one variable a Bonferroni
correctionwas performed following the repeated-measures model.
Improvement over time is, for all variables, presented as
average  standard deviation.
Conditions for regression analysis
A regression analysis was performed to evaluate possible re-
lations between our outcome variables. Before valid inclusioninto the regression model, all variables were subjected to a
normality test by the KolmogoroveSmirnov coefﬁcient, a test for
intervariable correlation and multicollinearity (Pearson correla-
tion coefﬁcient and the variance inﬂation factor) and an assess-
ment for autocorrelation (correlation within a single variable)
with the DurbineWatson coefﬁcient. Also, in multiple regression
analysis, the unstandardized residuals were evaluated for the
absence of intercorrelation and scatterplots were created to test
normal residual distribution and homoscedasticity. A Kolmo-
goroveSmirnov coefﬁcient with P > 0.05 indicates normal dis-
tribution while a variance inﬂation factor close to 0 or >5 was
considered indicative of multicollinearity. A DurbineWatson
coefﬁcient close to 0 is related to strong negative autocorrelation,
whereas a DurbineWatson close to 4 suggests strong positive
autocorrelation.
For each regression analysis, the B-coefﬁcient, standard error of
the B-coefﬁcient, the 95% conﬁdence interval (95% CI), the R2 and
P-value of the model were obtained. The B-coefﬁcient explains the
relation between the predictor and dependent variable where an
increase of 1 unit of the predictor results in an increase of the
dependent variable by the value of B. This relation is statistically
signiﬁcant if the P < 0.05 and causality counts for the percentage
expressed by the R2.
Linear regression analysis
Linear regression analysis was performed to evaluate
whether local regeneration (expressed by the 12 months
improvement in measured T1gd from baseline in the defect ROI)
inﬂuences other joint compartments. For this, a single linear
regression model was applied with the absolute improvement of
measured T1gd in the defect ROI as a predictor variable and the
absolute improvement of measured T1gd of the other ROIs
(articulating, treated, other 1, other 2 and whole) as dependent
variables.
Multiple regression analysis
Multiple linear regression with backward elimination was per-
formed to test what patient characteristics were related to
improvement in defect T1gd after 12 months. For all statistical
analysis a P-value of P < 0.05 was considered statistically
signiﬁcant.
Fig. 2. dGEMRIC at baseline and 12 months follow-up. The blue pixels represent a high
T1gd (1000 ms) while a low T1gd of 0 is labeled as red. At the preoperative situation a
clear change in signal (from yellow to red) is visible at the site of the lesion when
compared to the rest of the knee. At 12 months after surgery the overall signal in the
knee is improved (more blueegreen) with a clear signal improvement at the treated
defect site.
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dGEMRIC and clinical scores; improvement from baseline
The segmentation process was valid with a Cronbach’s alpha of
0.86 and an ICC of 0.91.
At baseline, the T1gd ranged from 365 to 484 ms for the
different ROIs (defect 365  46, articulating 484  125, treated
421  48, other 1 422  60, other 2 448  68, whole 432  54). The
KOOS scores at baseline were lowest for the sports and quality of
life subdomains (pain 59  19, activity of daily living 65  20,
symptoms 62  18, sports 27  22, quality of life 24  15). The
baseline Lysholm score was 48  21 points.
Except for the articulating ROI, the T1gd indices at 3 months
after surgery were slightly, but statistically non-signiﬁcantly,
decreased compared to the baseline values (Table II, defect
362  54, articulating 481 171, treated 407 68, other 1 411 61,
other 2 419  55, whole 415  58). After 12 months follow-up, the
T1gd of the defect and the articulating ROI showed the largest,
statistically signiﬁcant (P < 0.01) improvement from baseline
(defect 468  91, articulating 622  241), which was also clearly
visible on the dGEMRIC images (Fig. 2). In addition, the T1gd of the
other ROIs (treated 481  91, other 1 503  85, other 2 680  63,
whole 484  67) also showed a clear, and statistically signiﬁcant
(P < 0.01), improvement from baseline.
At 3 months after surgery, the clinical scores did not show a
statistically signiﬁcant change from baseline (Table II). However, at
12 months follow-up all but three patients showed clearly
improved clinical scores. Improvement from baseline was noted on
the Lysholm, the KOOS subdomains and the KOOS overall scores
(P < 0.01) (Table II).
Regression analysis; effect of defect treatment on distant cartilage
quality
All variables in the regression analysis had a normal distribution
(normality tests P > 0.358) and no multicollinearity or autocorre-
lation was found (variance inﬂation factor, 1.000; DurbineWatson
range, 2.199e2.510). Also scatterplots of model residuals showed
normal residual distribution and homoscedasticity of residuals.
The increase in T1gd after 12 months at the defect ROI was
signiﬁcantly related to the T1gd increase of the other ROIs in the
joint (Table III). The B-values ranged from 0.787 to 0.567 indicatingTable II
Clinical outcome evaluation
Baseline e 3 months Baseline e 12 months
KOOS questionnaire
Pain 12  4 (5e20)* 21  4 (13e29)*
Symptoms 4  4 (4e12) 15  4 (7e23)*
Activity 6  4 (1e14) 20  4 (13e27)*
Sports 1  4 (10e7) 29  5 (19e38)*
QoL 5  3 (1e11) 20  4 (13e28)*
Overall KOOS 6  3 (0e13) 20  3 (14e27)*
Lysholm 9  4 (1e17) 28  3 (21e35)*
ROIs
Defect 4  11 (26e18) 103  13 (76e130)*
Articulating 20  28 (36e76) 158  46 (65e252)*
Treated 19  10 (39e2) 49  18 (12e86)*
Other 1 11  10 (30e9) 78  16 (44e111)*
Other 2 16  10 (38e5) 44  14 (15e72)*
Whole 10  11 (32e12) 51  15 (13e74)*
Improvement from baseline [mean  SD and (95%CI)] after 3 and 12 months
(calculated by extracting the baseline values from the 3 and 12 month values) for
both the clinical questionnaires and dGEMRIC ROIs. *P < 0.01.that for eachmillisecond increase in T1gd at the treated defect after
12 months, the T1gd of the cartilage at another location in the joint
increased with 0.787e0.567 ms.
Multiple regression analysis showed that the patient charac-
teristics (gender, patient age, defect age and defect size) did not
inﬂuence (P > 0.070) the improvement in T1gd after 12 months for
the defect ROI. However, defect size and patient age were shown to
inﬂuence the improvement in T1gd of the whole ROI at 12 months
after surgery. A defect size >3 cm2 was related to 58  24 less in-
crease (P ¼ 0.024) in T1gd of the joint as a whole after 12 months
compared to defects <3 cm2 and in patients <30 years old a
152  47 stronger increase (P ¼ 0.005) in the T1gd was found
compared to those >30 years old at 12 months after surgery.
Discussion
This study evaluated the feasibility of non-invasive monitoring
by dGEMRIC of defect repair and general tissue integrity of cartilage
in the joint after cartilage repair surgery. The dGEMRIC scanning
technique was useful in detecting local cartilage repair in a focal
defect 1 year after treatment, which was accompanied by clearly
improved clinical scores. In addition, local improvement of T1gd
was directly related to the improvement of cartilage quality in other
joint compartments. Also, patient age and defect size inﬂuenced
the treatment response of the articular cartilage in the whole knee.
The International Cartilage Research Society has recently pub-
lished several guidelines for histological and MRI based evaluation
of cartilage repair studies17,18. Histological evaluation of newly
formed cartilage provides information on the structuralTable III
Defect treatment relates to overall cartilage improvement
Dependent variable B P-value 95%CI lower 95%CI upper
Treated T0T12 0.787 0.001 0.364 1.210
Other 1 T0T12 0.651 0.002 0.253 1.049
Other 2 T0T12 0.567 0.002 0.233 0.901
Whole 0.689 0.001 0.354 1.023
Linear regression analysis using the increase in T1gd from baseline to 12 months at
the defect ROI as a predictor for the increase in T1gd from baseline to 12 months at
other joint locations/ROIs. The B-value represents the increase in the dependent
variable when the increase in the predictor is 1. For example, when the T1gd at the
defect ROI improves with 1 ms in 12 months’ time the T1gd of the treated joint
compartment (treated ROI) improves with 0.787 explaining an inﬂuence of local
regeneration on cartilage quality in locations in the joint.
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tissue regeneration17. Disadvantages of histological evaluation are
the time consuming processing and the small volume of tissue that
can be analyzed. Moreover, the invasive nature of the necessary
biopsy makes longitudinal follow-up less desirable from an ethical
point of view. Contrast-enhanced MRI scanning protocols, such as
dGEMRIC, are able to represent tissue structure and can be readily
applied in a longitudinal follow-up. Moreover, with MRI the whole
joint can be assessed instead of only small tissue volumes after
biopsy.
Overall the dGEMRIC technique is reliable as repeated mea-
surements show a good reproducibility19e21. Also the coefﬁcient of
variation in the bulk T1gd for certain cartilage ROIs was 5%, ranging
from 4.2% to 5.5% for femur and tibia cartilage respectively19.
However, recent reports question the robustness of the physical
properties at which the dGEMRIC technique is based on. The
measurement of bulk T1gd values from articular cartilage 1.5 h after
scanning is based on the assumption of a steady state concentration
gradient at that time14. However, recently it was shown that the
depth-wise concentration gradient of Gd-DTPA2 is continuously
changing which could make bulk ROI measurements less reliable22.
In addition, the diffusion time of Gd-DTPA2 seemed slower than
previously assumed and the distribution of Gd-DTPA2 is also
inﬂuenced by the collagen content of the articular cartilage23. These
observations should be taken into account when dGEMRIC data is
being evaluated and one should be cautious to directly relate
measured T1gd to tissue GAGs. Abovementioned issues are the
limitation of dGEMRIC technique and manuscripts that directly
relate dGEMRIC ﬁndings to tissue GAG. In addition this study could
have been strengthened when also other quantitative MRI tech-
niques, such as T2 mapping or proton density sequences, were
added to the analysis. In addition, such scanning sequences are
more reliable in the assessment of a focal lesion and therefore will
lead to a more precise segmentation of the cartilage in the focal
defect area. This could prevent from an erroneous baseline T1gd
values of the defect ROI resulting from a segmentation that includes
limited amounts of the egadolinium containinge synovial ﬂuid in
the defect. Also longer follow-up would have provided more in-
formation on the use of non-invasive evaluation tools, such as
dGEMRIC, for the evaluation of articular cartilage following carti-
lage repair.
To our knowledge one study also compared the T1gd values
measured in a focal cartilage lesion to those 1 year after matrix-
associated ACI9. However, the main outcome parameter of that
study was to evaluate the zonal distribution of GAGs, using
dGEMRIC, in normal and repair tissue. Therefore, the study may
have been underpowered (n ¼ 15) to show statistically signiﬁcant
T1gd improvement between the preoperative and postoperative
scans. Therefore, this is the ﬁrst study to show that a dGEMRIC
scanning protocol can be used to longitudinally show improvement
in T1gd, as a possible representation of tissue GAG concentration,
following cartilage repair.
Several other groups already used dGEMRIC to evaluate articular
cartilage after ACI, but focussed on differences between repair and
native tissue, the zonal organization of the newly formed tissue or
only performed post-surgery dGEMRIC without baseline mea-
surements7,9,11,24. Considering the large variation in T1gd times
between patients, it is difﬁcult to deﬁne a consensus T1gd that
represents acceptable or good quality cartilage after regeneration.
Therefore, patient speciﬁc baseline measurements are essential
when cartilage quality following regenerative surgery is a relevant
outcome in a longitudinal study.
During the different phases of cartilage regeneration the orga-
nization of matrix constituents and water content change contin-
uously18. These factors inﬂuence the T1 relaxation time of thenewly formed tissue and most likely lead to differences of the
measured T1 relaxation times in repair tissue compared to the
reference healthy or degenerated cartilage18. This should be taken
into account when cartilage is being evaluated with the dGEMRIC
technique. A direct comparison, using only post-contrast imaging,
between repair tissue and other locations in the joint could,
therefore, introduce erroneous interpretation of the data and does
not represent the true GAG content in articular cartilage18. The
delta relaxation rate [DR1 ¼ 1/T1 precontrast  1/T1(Gd)] corrects
for the differences in precontrast T1 and is preferredwhen different
locations in the joint are being evaluated and compared in a
cross-sectional study design18. However, per location in the joint
(either repair or healthy reference tissue) the correlation between
the T1gd and DR1 is high and separate interpretation of both
outcome variables leads to similar conclusions25. The absence of
precontrast imaging, in this study, combined with a longitudinal
evaluation at predeﬁned locations does, for abovementioned
reason, not inﬂuence data interpretation nor change the ﬁnal
conclusions. In addition, patient comfort will decrease when also a
precontrast MRI scan was performed as scanning time would be
twice as long.
The clinical beneﬁt following ACI and microfracturing is inﬂu-
enced by speciﬁc characteristics of the defect or patient4,12,26e28.
Also, in speciﬁc cases one technique may perform better than the
other one does4,12,27,29. In this study, the size of the defect and age of
the patient showed a direct relation to the overall improvement in
T1gd of the articular cartilage in the knee, at 12 months after sur-
gery. This implies that speciﬁc biological characteristics of the
defect and patient could play a role in the intrinsic repair capacity of
the articular cartilage following surgery. The articular cartilage in
the knee showed less improvement following cartilage surgery
when a large defect (>3 cm2) had been present. Whether the size of
the defect is positively correlated to the severity of disturbance in
joint homeostasis remains to be seen, however, the presence of an
articular cartilage defect has been shown to induce joint cartilage
degeneration30. It has also been shown that larger defects, if left
untreated, are related to an increased cartilage volume loss31. Age
inﬂuenced the improvement in T1gd following cartilage surgery in
this study. Younger patients could be more sensitive for a regen-
erative response due to the senescence of cells and tissues related
to the effects of aging32.
Based on macroscopic and biochemical evaluation, the treat-
ment of an articular cartilage defect has been related to a decrease
in degenerative characteristics at other joint locations30. In this
study we showed, using regression analysis, that defect treatment
is related to the improvement of the T1gd at other locations in the
joint which could imply improved cartilage quality. These ﬁndings
underline the importance of the concept of joint homeostasis and
the role for early detection and intervention. The presence of an
articular defect should be regarded as indicative of a joint disease
rather than a local problem. Timely treatment has been shown to
improve clinical outcome, i.e., timely restoration of the joint ho-
meostasis improves the regenerative response of the whole
joint4,12. Using dGEMRIC, such changes can be monitored thereby
providing a reliable imaging tool for the evaluation of cartilage
quality in the whole joint following cartilage repair.
In conclusion, this study demonstrates that the dGEMRIC tech-
nique can be used to longitudinally measure changes in T1gd
following cartilage repair surgery. Also, using dGEMRIC we showed
that patient age and defect size inﬂuence the improvement in T1gd
following cartilage surgery and that local repair inﬂuences the T1gd
at distant locations in the joint. Taken together, these ﬁndings
illustrate the value of dGEMRIC for the evaluation of the effects of
cartilage repair and clearly indicate a role for early detection and
intervention.
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